Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06713525

Observational Copenhagen Pancreatic Cancer Study

The primary objective of the Copenhagen Pancreatic Cancer (COPAN) study is to describe the real-world population of patients with pancreatic cancer (PC). Larger sample of longitudinal real-world data provides a unique opportunity for comprehensive exploration of the diagnostic and treatment journey for individuals diagnosed with PC and allows to investigate treatment outcomes and associated prognostic factors. Furthermore, the study aims to identify determinants of treatment management and treatment outcomes, including patient-reported outcomes.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

The study objective is to describe the real-world population of patients with pancreatic cancer by collecting longitudinal data that facilitates a more rigorous understanding of the PC. This research project will catalog different elements of a patient's diagnostic and treatment journey and identify unmet needs of patients with PC.

The study aims to:

  • To compile detailed demographic information of patients with PC.
  • To document and analyze the clinical and disease characteristics at the time of diagnosis and beyond.
  • To track various treatment modalities employed, including surgery, chemotherapy, and radiation therapy.
  • To assess short-term and long-term outcomes, including survival rates, complications, and quality of life.
  • To identify prognostic and predictive factors within the real-world cohort.
  • To investigate the impact of PC and treatment on patients' quality of life.

4 Study Design This study of patients with PC will employ both a prospective, observational design and retrospective design to capture real-world data relating to health status and/or the delivery of health care routinely collected from a variety of sources. Data will be collected longitudinally, allowing for a dynamic analysis of the disease trajectory.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Histologically confirmed pancreatic cancer

Exclusion criteria

  • None

Treatment and study plan

Primary outcomes

  1. Overall survival

    Time frame: 3 years

Study contacts

Contact information is provided by the study sponsor or research team.

Inna Markovna Inna Markovna Chen, MD, Herlev & Gentofte Hospital, MD

CONTACT

[email protected]

+45 3868-2898

Sponsors and collaborators

Lead sponsor

Inna Chen, MD

Other

Registry information

Official study title

Copenhagen Pancreatic Cancer Study (COPAN)

Acronym: COPAN

Important dates

Study start
2025
Primary completion
2035
Study completion
2036
First posted
Dec 3, 2024
Registry last updated
Dec 3, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.